Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Medtronic
Colorcon
Citi
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo
AstraZeneca

Generated: August 19, 2018

DrugPatentWatch Database Preview

Dava Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for DAVA PHARMS INC, and what generic and branded alternatives to DAVA PHARMS INC drugs are available?

DAVA PHARMS INC has seventy-one approved drugs.



Summary for Dava Pharms Inc
US Patents:0
Tradenames:36
Ingredients:35
NDAs:71

Drugs and US Patents for Dava Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms Inc CAPTOPRIL captopril TABLET;ORAL 074423-002 Feb 13, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Dava Pharms Inc FUROSEMIDE furosemide TABLET;ORAL 018415-001 Jul 27, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Dava Pharms Inc GLYBURIDE (MICRONIZED) glyburide TABLET;ORAL 074591-003 Dec 22, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Dava Pharms Inc CHLORPROPAMIDE chlorpropamide TABLET;ORAL 089561-001 Sep 4, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Dava Pharms Inc ACYCLOVIR acyclovir TABLET;ORAL 074946-001 Nov 19, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Dava Pharms Inc CHLORTHALIDONE chlorthalidone TABLET;ORAL 087451-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Dava Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dava Pharms Inc VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 3,524,844 ➤ Try a Free Trial
Dava Pharms Inc VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 3,524,844 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Queensland Health
US Department of Justice
Cerilliant
Express Scripts
McKinsey
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.